Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of Pharmaceutical Formulations.
Mankind IPO: The shares are currently trading at Rs 1,168 in the gray market at a premium of Rs 88 to the upper band of Rs 1,080 per share.
Mankind IPO: Mankind Pharma’s Initial Public Offer, which was open for public subscription between April 25 and 27, received a good response with the offer being subscribed 15.32 times as it was subscribed for 42,95,12,902 shares against 2,80,41,192 Bids were received for Shares on offer.
humanity IPO gmp today
Shares of Mankind are currently trading at a premium of Rs 88 above the upper band of Rs 1,080 per share in the gray market. Hence, the shares are currently trading at Rs 1,168 on April 29 in the gray market. This indicates that the shares of the company are expected to be listed at a premium to its issue price on May 8, 2023. Fluctuates depending on the premium. sentiment in the markets.
Mankind IPO: How to check allotment status
Mankind Pharma will finalize the allotment by May 3, 2023. If not allotted, the refund will be processed on May 4. Once allotted, the shares will be credited to your demat on 5th May. Here’s how you can check the allotment status:
A) Visit the official website of BSE or Bombay Stock Exchange. link is (https://www.bseindia.com/investors/appli_check.aspx,
b) It will take you to a page called ‘Status of Issue Application’.
c) Once on the page, click on the option ‘Equity’
d) From the drop-down menu appearing along with the issue name, select the option ‘Mankind Pharma’
e) Write your application number on the page
f) Thereafter, enter your Permanent Account Number or PAN
g) Click on the captcha that says ‘I am not a robot’ and click on submit
h) Details of allotment status of your bid, once you have clicked on the option. The status will be visible only after the share allotment is finalised.
Mankind Pharma IPO: Basic Details
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations in various acute and chronic therapeutic areas as well as a number of consumer health care products.
It has established several distinct brands in the categories of condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.
It has a pan-India marketing presence and operates 25 manufacturing facilities across the country. By December 2022, the company had a team of over 600 scientists and a dedicated in-house R&D center with four units at IMT Manesar, Gurugram (Haryana) and Thane (Maharashtra).
The IPO was an offer for sale (OFS) of 40.06 million equity shares entirely by the promoters and other existing shareholders. Its price band was fixed at Rs 1,026-1,080 per share. Bidders placed bids for a minimum of one lot and a maximum of 13 lots in the Rs 4,326 crore IPO. There were 13 shares of Mankind Pharma in the lot.
The shares will be listed on NSE and BSE on May 8, 2023.
read all latest business news, tax news And stock market update Here
